Effects of combined estrogen+progestin hormone therapy on hepatic lipase and lipoprotein lipase levels

2005

Hepatic lipase and lipoprotein lipase are affected by combined estrogen+progestin hormone therapy

2004

Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with growth hormone deficiency before and after short-term replacement ther…

2007

Ethnic differences in serum lipoproteins and their determinants in South African women

2010

Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naïve patients with early rheumatoid arthritis.

2009

"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL sub…

2011

Item does not contain fulltext

Fasting and postprandial effects of rosiglitazone on low- and high-density lipoproteins size and subclasses in type-2 diabetes.

2010

The significance of low-density lipoproteins size in vascular diseases

2006

Low density lipoproteins (LDL) comprise in humans two different main fractions: large, buoyant and small, dense particles. Small, dense LDL particles correlate negatively with plasma HDL levels and positively with plasma triglyceride concentrations and are associated with the metabolic syndrome and increased risk for cardiovascular disease. LDL size seems to be an important predictor of cardiovascular events and progression of coronary heart disease (CHD). In addition, several studies have suggested that therapeutic modulation of specific LDL subclasses may be of great benefit in reducing the atherosclerotic risk. Therefore, LDL size measurement may be of potential value in the clinical ass…

Should we measure routinely oxidized and small dense low-density lipoproteins in subjects with type 2 diabetes

2010